NOVAVAX INC (NVAX) Stock Income Statement
NASDAQ:NVAX - Nasdaq - US6700024010 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.25B | 682.16M | 983.71M | 1.98B | 1.15B | |||
| Cost Of Goods | 156.65M | 201.74M | 343.27M | 902.60M | N/A | |||
| Gross Profit | 1.10B | 480.42M | 640.44M | 1.08B | N/A | |||
| Operating Expenses | 675.50M | 712.35M | 1.19B | 1.72B | 2.83B | |||
| Research and Development | 386.63M | 388.77M | 735.20M | 1.24B | 2.53B | |||
| Selling, General, and Administrative Expenses | 288.87M | 323.58M | 457.45M | 488.70M | 298.40M | |||
| Operating Income | 422.82M | -231.93M | -552.21M | -644.70M | -1.69B | |||
| Interest Income/Expense | -21.69M | -20.07M | -14.42M | -19.90M | -27.00M | |||
| Other Income/Expense | 46.84M | 40.44M | 37.90M | 11.00M | -1.00M | |||
| Non Recurring Items | -11.40M | -17.00M | -14.30M | N/A | 0.00 | |||
| Income Before Taxes | 488.52M | -176.62M | -543.03M | -653.60M | -1.71B | |||
| Income Tax | 9.82M | 10.88M | 2.03M | 4.30M | 29.20M | |||
| Net Income | 478.70M | -187.50M | -545.06M | -657.90M | -1.74B | |||
| EBITDA | 467.51M | -183.44M | -510.99M | -615.60M | -1.67B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.67 | -1.23 | -5.41 | -8.42 | -23.44 | |||
| Non GAAP EPS | 2.33 | -1.65 | -5.53 | -8.40 | -23.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 87.52% | 70.43% | 65.10% | 54.45% | N/A | |||
| Profit Margin | 38.14% | -27.49% | -55.41% | -33.20% | -152.12% | |||
| Operating Profit Margin | 33.69% | -34.00% | -56.14% | -32.53% | -147.13% | |||
All data in USD